PMID: 15243214Jul 10, 2004Paper

Current management of severe homozygous hypercholesterolaemias

Current Opinion in Lipidology
Rossi P NaoumovaAnne K Soutar

Abstract

This review focuses on recent advances in the management of patients with homozygous familial hypercholesterolaemia, autosomal recessive hypercholesterolaemia and familial defective apolipoprotein B. Autosomal recessive hypercholesterolaemia has been described as a 'phenocopy' of homozygous familial hypercholesterolaemia. Although the clinical phenotypes are similar, autosomal recessive hypercholesterolaemia seems to be less severe, more variable within a single family, and more responsive to lipid-lowering drug therapy. The cardiovascular complications of premature atherosclerosis are delayed in some individuals and involvement of the aortic root and valve is less common than in homozygous familial hypercholesterolaemia. Apheresis is still the treatment of choice in homozygous familial hypercholesterolaemia and in autosomal recessive hypercholesterolaemia patients in whom maximal drug therapy does not achieve adequate control. In addition to the profound cholesterol-lowering effects of apheresis, other potentially beneficial phenomena have been documented: improved vascular endothelial function and haemorheology, reduction in lipoprotein (a) and procoagulatory status, and a decrease in adhesion molecules and C-reactive protein...Continue Reading

References

Dec 13, 1975·Lancet·R W Griffiths
Jan 1, 1979·Annual Review of Genetics·J L Goldstein, M S Brown
Sep 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M Harada-ShibaA Yamamoto
Jan 1, 1990·American Journal of Obstetrics and Gynecology·Y BeigelJ Ovadia
Oct 19, 1985·British Medical Journal·R WestJ Lloyd
Jan 1, 1973·Nutrition and Metabolism·A K Khachadurian, S M Uthman
Mar 1, 1980·Atherosclerosis·A YamamotoA Endo
Jun 1, 1980·British Heart Journal·G R ThompsonR E Steiner
Jul 1, 1996·Heart·L RallidisG R Thompson
Jul 31, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·W O RichterP Schwandt
Sep 24, 1999·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Y KizakiK Yano
Nov 11, 1999·Current Opinion in Lipidology·K Kajinami, H Mabuchi
Dec 9, 2000·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·K G ParhoferP Schwandt
May 15, 2001·Journal of Computer Assisted Tomography·R M SummersR D Shamburek
Jul 7, 2001·Acta Paediatrica·C StefanuttiS Bertolini
Aug 8, 2001·The Journal of Clinical Investigation·L A Lee
Jan 5, 2002·Current Atherosclerosis Reports·A D MaraisJ C Firth

❮ Previous
Next ❯

Citations

Aug 28, 2012·Pharmaceutical Research·Stephen D LeeKishor M Wasan
Nov 1, 2005·Current Cardiology Reports·Kathryn Wood Holmes, Peter Oscar Kwiterovich
May 20, 2011·European Heart Journal·Fatima AkdimJohn J P Kastelein
Aug 16, 2005·The Heart Surgery Forum·Mehmet Salih BilalMehmet Kaplan
Aug 23, 2012·Vascular Health and Risk Management·Binh An P PhanPeter P Toth
Jan 1, 2011·Case Reports in Transplantation·Carlos H PalacioChristine A O'Mahony
Jul 6, 2014·Annals of Pediatric Cardiology·Mithun J Varghese
Mar 29, 2008·Atherosclerosis·G R Thompson, UNKNOWN HEART-UK LDL Apheresis Working Group
Nov 21, 2007·Molecular Genetics and Metabolism·Amit R Rahalkar, Robert A Hegele
Oct 12, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Irinel Popescu, Simona O Dima
Sep 18, 2010·Pediatric Transplantation·Arianna MaioranaAndrea Bartuli
Jan 18, 2006·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Robert G ElkinWolfgang J Schneider
Mar 9, 2012·Atherosclerosis·Frederick J Raal, Raul D Santos
Nov 21, 2014·Current Atherosclerosis Reports·Claudia Stefanutti, Gilbert R Thompson
Jul 21, 2016·Pediatric Transplantation·Altan AlimArzu Oezcelik
Sep 14, 2016·Current Treatment Options in Cardiovascular Medicine·Justin ParizoJoshua W Knowles
Apr 1, 2010·Obesity Research & Clinical Practice·Mahendra Narwaria, Lakshman S Khiria
Feb 24, 2009·Reproductive Sciences·Ahmet Basaran
Jun 8, 2018·Journal of Atherosclerosis and Thrombosis·Mariko Harada-ShibaUNKNOWN Working Group by Japan Atherosclerosis Society for Making Guidance of Familial Hypercholesterolemia
Oct 30, 2015·Circulation·Samuel S GiddingUNKNOWN American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascula
Feb 2, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Z AwanP Couture
Mar 10, 2010·Expert Opinion on Pharmacotherapy·D Meeike KustersBarbara A Hutten
Oct 26, 2012·Journal of Atherosclerosis and Thrombosis·Mariko Harada-ShibaShizuya Yamashita
Mar 22, 2019·Reviews on Recent Clinical Trials·Francesco SantopaoloLeonardo Baiocchi
Apr 22, 2017·Current Cardiology Reports·Kavita Sharma, Ragavendra R Baliga

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.